切换至 "中华医学电子期刊资源库"

中华移植杂志(电子版) ›› 2017, Vol. 11 ›› Issue (04) : 201 -205. doi: 10.3877/cma.j.issn.1674-3903.2017.04.002

所属专题: 专题评论 文献

论著

移植肾动脉狭窄诊断及介入治疗效果评价
陈忠宝1, 周江桥1,(), 邱涛1, 张龙1, 马枭雄1, 邹寄林1, 胡红耀2, 赵辉2, 吴振中2, 王畅2   
  1. 1. 430060 武汉大学人民医院器官移植科
    2. 430060 武汉大学人民医院介入科
  • 收稿日期:2017-10-20 出版日期:2017-11-25
  • 通信作者: 周江桥
  • 基金资助:
    国家自然科学青年基金(81400753)

Diagnosis and endovascular management of the transplant renal artery stenosis

Zhongbao Chen1, Jiangqiao Zhou1,(), Tao Qiu1, Long Zhang1, Xiaoxiong Ma1, Jilin Zou1, Hongyao Hu2, Hui Zhao2, Zhengzhong Wu2, Chang Wang2   

  1. 1. Department of Organ Transplantation, Renmin Hospital of Wuhan University, Wuhan 430060, China
    2. Department of Intervention, Renmin Hospital of Wuhan University, Wuhan 430060, China
  • Received:2017-10-20 Published:2017-11-25
  • Corresponding author: Jiangqiao Zhou
  • About author:
    Corresponding author: Zhou Jiangqiao
引用本文:

陈忠宝, 周江桥, 邱涛, 张龙, 马枭雄, 邹寄林, 胡红耀, 赵辉, 吴振中, 王畅. 移植肾动脉狭窄诊断及介入治疗效果评价[J/OL]. 中华移植杂志(电子版), 2017, 11(04): 201-205.

Zhongbao Chen, Jiangqiao Zhou, Tao Qiu, Long Zhang, Xiaoxiong Ma, Jilin Zou, Hongyao Hu, Hui Zhao, Zhengzhong Wu, Chang Wang. Diagnosis and endovascular management of the transplant renal artery stenosis[J/OL]. Chinese Journal of Transplantation(Electronic Edition), 2017, 11(04): 201-205.

目的

比较肾移植术后移植肾动脉狭窄(TRAS)不同诊断方法的价值并总结血管内介入治疗经验。

方法

回顾性分析2010年1月至2017年6月武汉大学人民医院器官移植科25例肾移植术后发生TRAS受者临床资料。所有受者均行移植肾彩色多普勒血流显像(CDFI)、磁共振血管成像(MRA)、移植肾数字减影血管造影(DSA)检查。TRAS经DSA确诊后立即行介入治疗,轻度狭窄受者术中予球囊扩张,中、重度狭窄受者根据球囊扩张后的狭窄段管径及长度植入合适动脉支架。根据移植肾动脉峰值流速(PSV)将TRAS受者分为高速血流组(PSV>120 cm/s)和低速血流组(PSV<50 cm/s),比较两组介入治疗前后移植肾动脉平均PSV和阻力指数。采用Fisher确切概率法比较CDFI与MRA对TRAS确诊率;采用配对t检验比较受者介入治疗前后24 h尿量、平均动脉压、血清肌酐、肾小球滤过率(GFR),采用配对t检验比较高速血流组和低速血流组平均PSV、阻力指数。P<0.05为差异有统计学意义。

结果

CDFI与MRA对TRAS确诊率分别为68%(17/25)、84.0%(21/25),差异无统计学意义(P=0.57)。DSA检查示轻、中、重度狭窄分别为7、13、5例。7例轻度狭窄受者均予术中球囊扩张;2例肾动脉主干近端及远端两处狭窄受者(重度狭窄)、1例肾动脉及1支副肾动脉均狭窄受者(重度狭窄)术中接受球囊扩张后再植入2根动脉支架;1例肾动脉及2支副肾动脉均狭窄受者(重度狭窄)术中接受球囊扩张后再植入3根动脉支架;余14例受者(中度狭窄13例、重度狭窄1例)术中接受球囊扩张后再植入1根动脉支架。介入治疗前后24 h尿量、平均动脉压、血清肌酐和GFR分别为(1 956±615)和(2 752±729)mL、(117±13)和(96±8)mmHg(1 mmHg=0.133 kPa)、(190±50)和(109±22)μmol/L、(39±12)和(66±8)mL/min,差异均有统计学意义(t=4.17、6.59、7.35、9.48,P均<0.05)。17例高速血流组介入治疗前后肾动脉平均PSV、阻力指数分别为(151±27)和(87±28)cm/s、(0.77±0.05)和(0.56±0.06),差异均有统计学意义(t=6.35、4.38,P均<0.05);8例低速血流组介入治疗前后肾动脉平均PSV、阻力指数分别为(39±9)和(80±16)cm/s、0.56±0.06和0.66±0.04,差异均有统计学意义(t=6.33、3.92,P均<0.05)。截至2017年10月,随访时间4~36个月,25例TRAS受者介入治疗后未见动脉血栓、再狭窄等并发症;介入治疗后分别各有1例出现上消化道出血、移植侧髂外静脉血栓,经治疗后均好转;1例于介入治疗后第3天出现肺部感染,1个月后因呼吸衰竭死亡。

结论

MRA与CDFI对于TRAS的诊断价值相似,介入治疗可明显改善TRAS患者相关症状,有效恢复其肾脏血流灌注、改善肾脏功能。

Objective

To compare the value of different diagnostic methods on transplant renal artery stenosis (TRAS) and summarize the treatment experience of interventional therapy on TRAS.

Methods

The clinical data of 25 recipients who suffered TRAS after renal transpantation in Renmin Hospital of Wuhan University from January 2010 to June 2017 were analysed. All recipients accepted color doppler flowing image (CDFI), magnetic resonance angiography (MRA) and digital subtraction angiography (DSA). Recipients received interventional therapy immediately after they were diagnosed with TRAS by DSA, mild stenosis recipients were treated with balloon dilatation, moderate stenosis and severe stenosis recipients were treated with balloon dilatation and artery stent. TRAS recipients were divided into fast blood flow group and slow blood flow group, the media peak systolic velocity (PSV) of transplant artery and resistance index between the 2 groups were compared. Diagnosis rate of CDFI and MRA on TRAS were compared with Fisher′s exact test. The indexes like 24 hour urine volume, mean arterial pressure, serum creatinine and glomerular filtration rate (GFR) before and after operation were compared with paired t test; the media PSV and resistance index of fast blood flow group and slow blood flow group were also compared with paired t test. P<0.05 was considered statitically significant.

Results

Diagnosis rate of CDFI and MRA on TRAS were 68% (17/25) and 84.0% (21/25), which had no statitical significance (P=0.57). The test results of DSA showed that there were 7 cases of mild stenosis recipients, 13 cases of moderate stenosis recipients and 5 cases of severe stenosis recipients. All the mild stenosis recipients received balloon dilatation, other recipients received balloon dilatation and artery stent. Twenty-four hour urine volume, mean arterial pressure, serum creatinine and GFR of fast blood flow group and slow blood flow group before and after operation were (1 956±615) and (2 752±729) mL, (117±13) and (96±8) mmHg, (190±50) and (109±22) μmol/L, (39±12) and (66±8) mL/min, all of them had statitical significance (t=4.17, 6.59, 7.35, 9.48, P all<0.05). Media PSV and resistance index of fast blood flow group (n=17) before and after operation were (151±27) and (87±28) cm/s, 0.77±0.05 and 0.56±0.06, all of them had statitical significance (t=6.35, 4.38, P all<0.05). Media PSV and resistance index of slow blood flow group (n=8) before and after operation were (39±9) and (80±16) cm/s, (0.56±0.06) and (0.66±0.04), all of them had statitical significance (t=6.33, 3.92, P all<0.05). Postoperative follow-up time of 25 TRAS recipients was 4-36 months up to October 2017, complications like artery thrombosis and restenosis were not observed; gastrointestinal bleeding (n=1) and vena iliaca externa thrombosis (n=1) were observed after interventional therapy; 1 case catched pulmonary infection on the third day after interventional therapy and died of respiratory failure 1 month later.

Conclusions

MRA and CDFI perform similar value in diagnosing TRAS. Interventional therapycould rectify the clinical symptoms and renal function by restoring transplant renal blood filtration.

1
Bruno S,Remuzzi G,Ruggenenti P. Transplant renal artery stenosis[J]. J Am Soc Nephrol, 2004, 15(1): 134-141.
2
杜杨春,陈正,廖德怀, 等. 移植肾动脉狭窄的诊断和治疗探讨[J]. 广东医学, 2010, 31(17): 2278-2281.
3
姜伟,高建,刘彦斌, 等. 移植肾动脉血管并发症29例报道并文献复习[J]. 器官移植, 2015, 6(4): 258-261.
4
刘亚民,吕良山,田红燕, 等. 肾动脉狭窄的介入治疗[J]. 中国医学影像学杂志, 2004, 12(4): 262-265.
5
邹英华. 重新认识肾动脉狭窄的发生与发展,规范肾动脉狭窄的介入治疗[J]. 介入放射学杂志, 2007, 16(7): 433-435.
6
梅秀荣. 彩色多普勒超声在动脉粥样硬化性肾动脉狭窄诊断中的应用[J]. 医药前沿, 2014, (35): 185-186.
7
Touma J,Costanzo A,Boura B, et al. Endovascular management of transplant renal artery stenosis[J]. J Vasc Surg, 2014, 59(4): 1058-1065.
8
刘燕娜,苗芸. 移植肾动脉狭窄的病因与发病机制[J]. 中华器官移植杂志, 2016, 37(1): 56-58.
9
Kamali K,Abbasi MA,Behzadi AH, et al. Incidence and risk factors of transplant renal artery stenosis in living unrelated donor renal transplantation[J]. J Ren Care, 2010, 36(3): 149-152.
10
Lechevallier E,Bretheau D,Berland Y, et al. Outcome of kidney transplants with multiple arteries[J]. Prog Urol, 1995, 5(3): 370-376.
11
Salsamendi J,Pereira K,Baker R, et al. Successful technical and clinical outcome using a second generation balloon expandable coronary stent for transplant renal artery stenosis: Our experience[J]. J Radiol Case Rep, 2015, 9(10): 9-17.
12
Hedegard W,Saad WE,Davies MG. Management of vascular and nonvascular complications after renal transplantation[J]. Tech Vasc Interv Radiol, 2009, 12(4): 240-262.
13
Tafur-Soto JD,White CJ. Renal artery stenosis[J]. Cardiol Clin, 2015, 33(1): 59-73.
14
王旭珍,薛武军,丁小明, 等. 彩色多普勒超声诊断移植肾动脉狭窄的临床应用价值[J]. 中华器官移植杂志, 2016, 37(9): 537-540.
15
Abuagla EM,Pei TS. Utility of color doppler ultrasound in the evaluation of renal artery stenosis in comparison with contrast-enhanced magnetic resonance angiography[J]. Saudi J Kidney Dis Transpl, 2014, 25(2): 309-315.
16
Braga AF,Catto RC,Dalio MB, et al. Endovascular approach to transplant renal artery stenosis[J]. Ann Transplant, 2015, 20: 698-706.
[1] 王亚红, 蔡胜, 葛志通, 杨筱, 李建初. 颅骨骨膜窦的超声表现一例[J/OL]. 中华医学超声杂志(电子版), 2024, 21(11): 1089-1091.
[2] 唐金侨, 叶宇佳, 王港, 赵彬, 马艳宁. 医学影像学检查方法在颞下颌关节紊乱病中临床应用研究进展[J/OL]. 中华口腔医学研究杂志(电子版), 2024, 18(06): 406-411.
[3] 屈翔宇, 张懿刚, 李浩令, 邱天, 谈燚. USP24及其共表达肿瘤代谢基因在肝细胞癌中的诊断和预后预测作用[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 659-662.
[4] 赵林娟, 吕婕, 王文胜, 马德茂, 侯涛. 超声引导下染色剂标记切缘的梭柱型和圆柱型保乳区段切除术的效果研究[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 634-637.
[5] 熊鹰, 林敬莱, 白奇, 郭剑明, 王烁. 肾癌自动化病理诊断:AI离临床还有多远?[J/OL]. 中华腔镜泌尿外科杂志(电子版), 2024, 18(06): 535-540.
[6] 袁雨涵, 杨盛力. 体液和组织蛋白质组学分析在肝癌早期分子诊断中的研究进展[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 883-888.
[7] 王秋生. 胆道良性疾病诊疗策略[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 779-782.
[8] 中华医学会器官移植学分会. 肝移植术后缺血性胆道病变诊断与治疗中国实践指南[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 739-748.
[9] 郑大雯, 王健东. 胆囊癌辅助诊断研究进展[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 769-773.
[10] 李浩, 陈棋帅, 费发珠, 张宁伟, 李元东, 王硕晨, 任宾. 慢性肝病肝纤维化无创诊断的研究进展[J/OL]. 中华临床医师杂志(电子版), 2024, 18(09): 863-867.
[11] 谭瑞义. 小细胞骨肉瘤诊断及治疗研究现状与进展[J/OL]. 中华临床医师杂志(电子版), 2024, 18(08): 781-784.
[12] 王子阳, 王宏宾, 刘晓旌. 血清标志物对甲胎蛋白阴性肝细胞癌诊断的研究进展[J/OL]. 中华临床医师杂志(电子版), 2024, 18(07): 677-681.
[13] 陈慧, 邹祖鹏, 周田田, 张艺丹, 张海萍. 皮肤镜对头皮红斑性皮肤病辅助鉴别诊断的研究进展[J/OL]. 中华临床医师杂志(电子版), 2024, 18(07): 692-698.
[14] 胡云鹤, 周玉焯, 付瑞瑛, 于凡, 李爱东. CHS-DRG付费制度下GB1分组住院费用影响因素分析与管理策略探讨[J/OL]. 中华临床医师杂志(电子版), 2024, 18(06): 568-574.
[15] 奚培培, 周加军. 慢性肾脏病患者肌少症机制和诊治的研究进展[J/OL]. 中华临床医师杂志(电子版), 2024, 18(05): 491-495.
阅读次数
全文


摘要